Albumin-bound Paclitaxel and Carboplatin Versus Epirubicin and Docetaxel for Triple-negative Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Albumin-bound paclitaxel combined with carboplatin|DRUG: Epirubicin combined with docetaxel
Sponsor: Shengjing Hospital